tiprankstipranks
Advertisement
Advertisement

BRRGF Stock Latest News

Oncoinvent Secures Key Chinese Patent for Lead Radiopharmaceutical Radspherin
Company AnnouncementsOncoinvent Secures Key Chinese Patent for Lead Radiopharmaceutical Radspherin
11d ago
Oncoinvent Grants CEO New Share Options as It Advances Radiopharmaceutical Pipeline
PremiumCompany Announcements
Oncoinvent Grants CEO New Share Options as It Advances Radiopharmaceutical Pipeline
18d ago
Oncoinvent Posts Strong 2H 2025 as Radspherin Data and Oslo Uplisting Bolster Growth Plans
PremiumCompany Announcements
Oncoinvent Posts Strong 2H 2025 as Radspherin Data and Oslo Uplisting Bolster Growth Plans
1M ago
Oncoinvent Registers Share Capital Increase Ahead of Reverse Share Split
PremiumCompany Announcements
Oncoinvent Registers Share Capital Increase Ahead of Reverse Share Split
2M ago
Oncoinvent Launches 100-for-1 Reverse Share Split and New ISIN on Oslo Bourse
PremiumCompany Announcements
Oncoinvent Launches 100-for-1 Reverse Share Split and New ISIN on Oslo Bourse
2M ago
Oncoinvent Grants New CEO Multiyear Share Option Package Tied to Long-Term Growth
PremiumCompany AnnouncementsOncoinvent Grants New CEO Multiyear Share Option Package Tied to Long-Term Growth
3M ago
Oncoinvent Reshapes Capital Structure After Extraordinary General Meeting
Premium
Company Announcements
Oncoinvent Reshapes Capital Structure After Extraordinary General Meeting
3M ago
Oncoinvent Revamps Option Scheme and Issues New Grants After BerGenBio Merger
Premium
Company Announcements
Oncoinvent Revamps Option Scheme and Issues New Grants After BerGenBio Merger
3M ago
Oncoinvent Calls Extraordinary General Meeting to Reshape Capital Structure
PremiumCompany Announcements
Oncoinvent Calls Extraordinary General Meeting to Reshape Capital Structure
3M ago
Oncoinvent ASA Completes Rights Issue and Share Capital Adjustment
PremiumCompany Announcements
Oncoinvent ASA Completes Rights Issue and Share Capital Adjustment
4M ago
Oncoinvent’s Radspherin® Shows Promise in Ovarian Cancer Treatment
PremiumCompany Announcements
Oncoinvent’s Radspherin® Shows Promise in Ovarian Cancer Treatment
4M ago
Oncoinvent ASA Announces Rights Issue and Underwriting Commission
PremiumCompany Announcements
Oncoinvent ASA Announces Rights Issue and Underwriting Commission
4M ago
Oncoinvent ASA Completes Major Rights Issue
PremiumCompany AnnouncementsOncoinvent ASA Completes Major Rights Issue
4M ago
Oncoinvent ASA Completes NOK 130 Million Rights Issue to Bolster Cancer Therapy Development
Premium
Company Announcements
Oncoinvent ASA Completes NOK 130 Million Rights Issue to Bolster Cancer Therapy Development
4M ago
Oncoinvent ASA Completes Subscription Period for Rights Issue
Premium
Company Announcements
Oncoinvent ASA Completes Subscription Period for Rights Issue
4M ago
Oncoinvent ASA Rights Issue Subscription Period Closes
PremiumCompany Announcements
Oncoinvent ASA Rights Issue Subscription Period Closes
4M ago
Oncoinvent ASA Completes Major Rights Issue with Insider Participation
PremiumCompany Announcements
Oncoinvent ASA Completes Major Rights Issue with Insider Participation
4M ago
Oncoinvent ASA Rights Issue Nears Completion
PremiumCompany Announcements
Oncoinvent ASA Rights Issue Nears Completion
4M ago
Oncoinvent ASA Launches NOK 130 Million Rights Issue
PremiumCompany Announcements
Oncoinvent ASA Launches NOK 130 Million Rights Issue
4M ago
Oncoinvent ASA Announces Extraordinary General Meeting for Rights Issue Approval
PremiumCompany AnnouncementsOncoinvent ASA Announces Extraordinary General Meeting for Rights Issue Approval
5M ago
Oncoinvent ASA Launches NOK 130 Million Rights Issue to Advance Cancer Therapy Development
Premium
Company Announcements
Oncoinvent ASA Launches NOK 130 Million Rights Issue to Advance Cancer Therapy Development
5M ago
Oncoinvent ASA Announces NOK 130 Million Rights Issue to Advance Cancer Therapy Development
Premium
Company Announcements
Oncoinvent ASA Announces NOK 130 Million Rights Issue to Advance Cancer Therapy Development
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >